320 related articles for article (PubMed ID: 2994208)
1. [Prevalence of antibodies against HTLV-III in various regions in Switzerland].
Schüpbach J; Vogt M; Bhushan R; Lüthy R; Haller O; Joller H; Ferber T; Büchner S; Schuppli R; Schädelin J
Schweiz Med Wochenschr; 1985 Jul; 115(30):1048-54. PubMed ID: 2994208
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS.
Schüpbach J; Haller O; Vogt M; Lüthy R; Joller H; Oelz O; Popovic M; Sarngadharan MG; Gallo RC
N Engl J Med; 1985 Jan; 312(5):265-70. PubMed ID: 2981407
[TBL] [Abstract][Full Text] [Related]
3. Unique pattern of HTLV-III (AIDS-related) antigen recognition by sera from African children in Uganda (1972).
Saxinger C; Levine PH; Dean A; Lange-Wantzin G; Gallo R
Cancer Res; 1985 Sep; 45(9 Suppl):4624s-4626s. PubMed ID: 2990697
[TBL] [Abstract][Full Text] [Related]
4. HTLV-III: the etiologic agent of AIDS.
Sarngadharan MG; DeVico AL; Bruch L; Schüpbach J; Gallo RC
Princess Takamatsu Symp; 1984; 15():301-8. PubMed ID: 6100648
[TBL] [Abstract][Full Text] [Related]
5. HIV and HTLV-I antibody studies: pregnant women in the 1960s, patients with AIDS, homosexuals, and individuals with tropical spastic paraparesis.
Madden DL; Tzan NR; Roman GC; Detels R; Mundon FK; Fuccillo DA; Sever JL
Yale J Biol Med; 1987; 60(6):569-74. PubMed ID: 2893497
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of antibodies to HTLV-III in AIDS risk groups in West Germany.
Erfle V; Hehlmann R; Mellert W; Krüger G; Seifried E; Heimpel H; Rasokat H; Lechler E; Holzer E; Hellstern P
Cancer Res; 1985 Sep; 45(9 Suppl):4627s-4629s. PubMed ID: 3860292
[TBL] [Abstract][Full Text] [Related]
7. [Antibodies against human T-cell leukemia virus type III in acquired immunodeficiency syndrome and persistent lymphadenopathy].
Wernicke D; v d Helm K; Abb J; Eberle J; Zoulek G; Pleyl G; Deinhardt F; Riethmüller G; Ziegler-Heitbrock HW; Rieber EP
Dtsch Med Wochenschr; 1984 Nov; 109(45):1709-11. PubMed ID: 6094134
[TBL] [Abstract][Full Text] [Related]
8. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
[TBL] [Abstract][Full Text] [Related]
9. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
[TBL] [Abstract][Full Text] [Related]
10. Human T-lymphotropic retrovirus type III (HTLV-III) in Danish homosexuals.
Lange Wantzin G; Saxinger WC; Weismann K; Gallo RC
Acta Derm Venereol; 1985; 65(3):247-50. PubMed ID: 2411083
[TBL] [Abstract][Full Text] [Related]
11. Epidemiological survey of HIV infection in the Veneto region of Italy.
Chieco Bianchi L; Faulkner Valle G; De Rossi A; Dalla Gassa O
Biomed Pharmacother; 1987; 41(3):139-43. PubMed ID: 3038208
[TBL] [Abstract][Full Text] [Related]
12. HTLV-III AIDS link.
Bennett JA
Am J Nurs; 1985 Oct; 85(10):1086-9. PubMed ID: 2996353
[TBL] [Abstract][Full Text] [Related]
13. Immunological properties of HTLV-III antigens recognized by sera of patients with AIDS and AIDS-related complex and of asymptomatic carriers of HTLV-III infection.
Sarngadharan MG; diMarzo Veronese F; Lee S; Gallo RC
Cancer Res; 1985 Sep; 45(9 Suppl):4574s-4577s. PubMed ID: 2410106
[TBL] [Abstract][Full Text] [Related]
14. HTLV-III infection in Canada in 1985.
Neumann PW; Benning BJ; Robinson DG; Gilmore N; O'Shaughnessy MV
CMAJ; 1986 Sep; 135(5):477-80. PubMed ID: 3461870
[TBL] [Abstract][Full Text] [Related]
15. [Detection of HTLV-III antibodies using ELISA and the western blot].
Kunz C; Heinz FX
Wien Klin Wochenschr; 1985 Nov; 97(22):829-32. PubMed ID: 3002046
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of HTLV-III/LAV antibody in selected populations in Thailand.
Wangroongsarb Y; Weniger BG; Wasi C; Traisupa A; Kunasol P; Rojanapithayakorn W; Fucharoen S
Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):517-20. PubMed ID: 3869739
[TBL] [Abstract][Full Text] [Related]
17. Screening for AIDS.
Med Lett Drugs Ther; 1985 Mar; 27(684):29-30. PubMed ID: 2984526
[TBL] [Abstract][Full Text] [Related]
18. Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex.
Resnick L; diMarzo-Veronese F; Schüpbach J; Tourtellotte WW; Ho DD; Müller F; Shapshak P; Vogt M; Groopman JE; Markham PD
N Engl J Med; 1985 Dec; 313(24):1498-504. PubMed ID: 2999592
[TBL] [Abstract][Full Text] [Related]
19. Relation of HTLV-III seropositivity and lymphadenopathy.
Jeffries E; Boyko WJ; Willoughby B; Constance PD; Wiggs B; O'Shaughnessy M; Sharp FR
Can Med Assoc J; 1985 Jul; 133(2):111-2. PubMed ID: 2988732
[TBL] [Abstract][Full Text] [Related]
20. HTLV and immunosuppression.
Essex M; Kanki P; Allan J; Barin F; McLane MF; Lee TH; Kitchen L; Homma T; Malone G; Yokota T
Princess Takamatsu Symp; 1984; 15():309-18. PubMed ID: 6100649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
